Not rendering correctly? View this email as a web page here.
LA Masthead.jpg

LAUNCH ANGELS administers and supports alumni venture capital funds. Our funds are private, for profit, and not affiliated with their respective schools. We send this report of recent company activity every two months to update investors and key supporters on recent fund deal activity and Launch Angels news.

Bascom Ventures (University of Wisconsin)  º  Blue Ivy Ventures (Yale)  º  Castor Ventures (MIT)
 º  Chestnut Street Ventures (University of Pennsylvania)
 º  The Farm Ventures (Stanford)  º  Green D Ventures (Dartmouth)  
º  Purple Arch Ventures (Northwestern)  º  Strawberry Creek Ventures (UC Berkeley)  
º  The Yard Ventures (Harvard)


While many in the venture industry slow down during the summer, we’ve been busy. Our full-time deal teams closed nine deals recently. We love the quality and diversity of our new investments.

We now have nine active funds, with almost 20 full-time deal team members working out of offices in Manchester, Waltham, Wilmington, Chicago, and San Francisco. Combining our alumni network of 75,000 supporters with our hard-driving teams gives us access to one of the most active deal flows in the industry. And we’re not done growing yet—see more in our Funds update below. We are truly better together.

Finally, say hello to Alumni Ventures Group (AVG), our new corporate name. We will be rolling out this change gradually, with the goal of completing by year end. The rebrand from Launch Angels better represents our focus and unique niche.



Online direct-to-consumer retailer of modular couches that aims to make the couch-buying process easier, faster, and less expensive. We participated in a seed round, following earlier rounds led by Y Combinator and Red & Blue Ventures. Chestnut Street.



Biotech company that provides cancer treatment through combinations, comprehensively drugging the tumor-immune synapse with human antibodies. Past and current co-investors include OrbiMed, F-Prime Capital Partners, Borealis Ventures, GV (Google Ventures), and Thiel Capital. Green D 4.

Screen Shot 2017-08-02 at 10.58.22 AM.png


Tool that lets you highlight web content to share with others in a way that's more personal and digestible than shared links. Co-investors in the seed round were Bloomberg Beta and Resolute Ventures. Bascom.



Med-tech startup whose mission is to develop innovative advanced energy medical devices. Inflection Equity led this Series A. Purple Arch.



Producer of demand orchestration software that enables marketers to automate top-of-funnel demand marketing to scale their pipeline and revenue. Foundry Group led the Series D round. Green D 3, Chestnut Street.


Online marketplace for corporate events and promotions that makes planning and managing events easy, effective, and scalable. We participated in Series B-2, led by NCT Ventures and Corazon Capital, that also included Drive Capital (ex-Sequoia).



Developer of respiratory-monitoring systems designed to non-invasively measure minute ventilation, enabling physicians to acquire exact data on patients. The pre-Series D note was led by Mehta Ventures. Castor.



Photo and video management platform that uses software to analyze images and videos for each construction project and match them to a set of tags, enabling clients to manage, search, and assess large volumes of data. The Series B was led by Autodesk and Borealis Ventures. Castor and syndication.



Data management platform that is used by 400+ partners to collect, organize, and monetize their exclusive audience data in the sports and entertainment verticals. Series A investors included owners of six professional sports teams (past investors include Greycroft and Sierra Wasatch). Purple Arch, Chestnut Street.



New funds for the second half of 2017 include Green D 4 (Dartmouth), Castor 2 (MIT), Blue Ivy 2 (Yale), and The Yard 2 (Harvard) funds. If you're an accredited investor who would like to participate, please reserve your spot by clicking on the fund names below.


In January of 2018, we anticipate launching three new funds. The offerings will include two alumni funds (Columbia and Michigan) and one specialty fund (Later Stage Venture Fund). This will bring the total number of our funds to 13. More launches are on our target list for later in 2018.



We continue to build out our portals for investors with additional features and functions. Investors now enjoy more real-time and deep information about their portfolio and companies in our Investor Portal (see screenshot). In addition, through our Closing Portal, we have addressed requests to make investor funding faster and easier by creating a simple ACH payments option (see screenshot).

IPVisual.jpgClosing Portal2.jpg


JoshLeviine.jpgWe have one new hire to announce and transitions for two Managing Partners.

JOSH LEVINE, VP of Marketing. We're pleased to welcome Josh to Launch Angels. He has had a distinguished career as a brand builder and marketing leader for top global consumer and tech brands Google, Gillette/P&G, and Bose. In addition, he served as a Captain in the US Army. He has a BSE from Princeton and MBA from HBS.  

MIKE COLLINS, Green D Managing Partner. 
Starting with Green D 5, Mike will be devoting all his time to his role as CEO of Launch Angels. He will remain engaged with Green D as MP Emeritus and Investment Committee member.


ALAIN.jpgALAIN HANOVER, Castor Managing Partner. Alain will be moving to MP Emeritus and IC advisor. In addition, he will serve as a Cambridge Venture Advisor, sourcing deals for all Launch Angels funds in the Cambridge area.

LA-JPG copy 2-1.jpg

Launch Angels Management Company, LLC (LAMC) is a Massachusetts-based venture capital firm. P
ast performance of LAMC funds may not be indicative of future results of any fund offered by LAMC. Different types of investments involve varying degrees of risk, and venture capital funds, including those offered by LAMC, involve substantial risk of loss, including loss of all capital invested. Moreover, you should not assume that any of the above content serves as the receipt of, or as a substitute for, personalized investment advice. Our fund offerings are made solely to accredited investors who accept the responsibility for conducting their own analysis of the investment and consulting with their professional advisors with respect to their analysis of this investment. Early-stage companies are risky investments, not suitable for all investors.